U.S. Industrial REITs Stock News

Colgate-Palmolive (CL) recently closed at $91.95, drawing attention from investors reviewing its latest financial profile. The company reports revenue of $21.0b and net income of $2.0b, supported by annual revenue and net income growth figures. See our latest analysis for Colgate-Palmolive. Over the past year Colgate-Palmolive’s share price return has been positive, with an 18.36% year to date share price gain and a 10.79% total shareholder return over 12 months, suggesting momentum has been...

Lineage, Inc. has released its second-quarter and six-month 2026 results, showing sales of US$1,361 million and US$2,658 million respectively, alongside net losses of US$29 million for the quarter and US$75 million for the half-year, both larger than the prior-year periods. While revenue inched higher year on year, the sharp increase in net loss and loss per share highlights rising cost or margin pressures that investors are likely examining closely. We will now examine how the widening net...

Super Group (SGHC) (NYSE:SGHC) is back in focus after raising its full year 2026 earnings guidance and reporting stronger second quarter revenue and net income compared with the prior year period. See our latest analysis for Super Group (SGHC). At a latest share price of $13.30, Super Group (SGHC) has a year to date share price return of 14.26% and a 1 year total shareholder return of 19.84%, with a very large 3 year total shareholder return that points to long running positive momentum...

Why Performance Food Group Stock Is Back in Focus Performance Food Group (PFGC) is back on investors radar after reporting fourth quarter and full year results, alongside fresh fiscal 2027 sales guidance, that together give a clearer picture of its current trajectory. See our latest analysis for Performance Food Group. Performance Food Group shares closed at US$107.25 after the earnings release, with a 1 day share price return of 2.65%. Short term momentum has cooled with a 7 day share price...

Main Street Capital Corporation recently reported past Q2 2026 results showing revenue of US$149.57 million and net income of US$147.58 million, alongside Board approval of regular monthly dividends of US$0.265 per share for Q4 2026 and a US$0.30 per share supplemental cash dividend funded from undistributed taxable income. These developments highlight how Main Street Capital is pairing higher earnings per share with continued cash returns to shareholders, while also tapping the equity...

In August 2026, HII announced that its Mission Technologies division secured a US$2.20 billion STRINGRAI task order for U.S. Southern Command, while the Defense Innovation Unit confirmed successful completion of HII’s PRIME prototype featuring the Watcher small unmanned surface vessel based on the ROMULUS-25 platform. Together with new automation alliances in shipbuilding, these wins highlight how HII is expanding beyond traditional shipyards into higher-tech intelligence, autonomy, and...

WESCO International has delivered very strong share price returns over the past five years, and the current valuation screens suggest the stock may still trade below an estimate of its intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples. WESCO International has returned 239.3% over the past 5 years, which puts extra focus on whether the current price still leaves room for further value to be realised. The key support for the valuation can come from the...

Chord Energy (CHRD) just paired strong second quarter earnings with higher oil production, fresh guidance, and an updated capital return plan, giving you several new data points to weigh the stock. See our latest analysis for Chord Energy. The latest Q2 update, dividend affirmation, and ongoing buybacks have arrived against a strong backdrop for Chord Energy, with the share price up 45.04% year to date, giving back 7.46% over 3 months, and delivering a 5 year total shareholder return of...

Earlier in August 2026, Structure Therapeutics appointed industry veteran John Berrios as Chief Commercial Officer and outlined upcoming aleniglipron trial readouts, while reporting a higher second-quarter net loss of US$106.16 million and basic loss per share of US$1.47 year on year. The combination of a commercially focused leadership hire from Novo Nordisk and detailed timelines for obesity and diabetes trials could influence how investors view Structure Therapeutics’ long-term...

Central Bancompany (CBC) shares are in focus after the company reported second quarter and six month 2026 results, announced a new US$100 million buyback plan, and affirmed its quarterly cash dividend. See our latest analysis for Central Bancompany. Central Bancompany’s share price has pulled back slightly in the past week, yet the 30 day share price return of 4.24% and year to date share price return of 36.98% suggest momentum has been building, reinforced by recent earnings, buyback and...

LandBridge (LB) is drawing attention after its second quarter 2026 earnings, a quarterly dividend declaration, and fresh commentary on an active acquisition pipeline tied to its Delaware Basin surface and infrastructure portfolio. See our latest analysis for LandBridge. LandBridge's recent news on record Q2 2026 results, the ongoing conversion to a Texas corporation, and an active M&A pipeline comes alongside strong share price momentum, with a year to date share price return of 62.38% and a...

Digital Turbine, Inc. reported past first-quarter 2026 results with sales of US$165.98 million versus US$130.93 million a year earlier, while trimming its net loss to US$3.16 million from US$14.10 million and reducing basic and diluted loss per share from US$0.13 to US$0.03. The company also raised its revenue guidance for fiscal 2027 to a range of US$650 million to US$670 million, signaling management’s increased confidence in the business following improved quarterly performance. We’ll now...

In the past few days, Rosen Law Firm announced an investigation into potential securities claims against PennyMac Financial Services, following allegations that the company may have provided materially misleading business information amid a significant drop in servicing segment pretax income. This legal scrutiny introduces fresh uncertainty around PennyMac’s past disclosures and risk controls, raising questions about how resilient its business model and reporting practices may be under...

What Enpro’s Updated Outlook Means For Investors Enpro (NPO) raised its 2026 earnings guidance on 4 August 2026, now projecting revenue growth of 14% to 16% compared to 10% to 14% a year ago. This update followed the company’s second quarter earnings release. For investors, the combination of refreshed guidance and recent results provides a clearer snapshot of how Enpro’s current operations in sealing and advanced surface technologies are feeding into near term expectations. See our latest...

In the past quarter, Ardent Health, Inc. reported second-quarter 2026 sales of US$1,622.25 million and net income of US$16.9 million, alongside lower full-year 2026 earnings guidance and updated expectations for total revenue between US$6.40 billion and US$6.70 billion. Despite softer earnings and trimmed guidance, Ardent continued repurchasing shares under its existing buyback and drew heightened attention in the options market, where elevated implied volatility on certain contracts...

Calumet (CLMT) has been in focus after a sharp stock move that followed stronger second quarter 2026 results, improved leverage metrics, and firm crude prices linked to fresh risks around the Strait of Hormuz. See our latest analysis for Calumet. Calumet's share price has swung sharply over 2026, with a 7 day share price return of 20.9% and a 90 day share price return of 52.1%, while the 1 year total shareholder return is very large. This suggests strong momentum following the second quarter...

Establishment Labs Holdings (ESTA) drew investor attention after reporting second quarter 2026 results with higher sales and a smaller net loss than a year earlier, along with slightly raised full year revenue guidance. See our latest analysis for Establishment Labs Holdings. At a share price of $79.47, Establishment Labs Holdings has a 1 day share price return of 5.13% and a 90 day share price return of 20.85%, while the 1 year total shareholder return of 107.39% points to strong momentum...

In August 2026, Sharplink, Inc. reported second-quarter revenue of US$11.53 million and a net loss of about US$394.27 million, while separately committing US$200 million of its Ethereum treasury to Lido’s liquid staking protocol and launching the Galaxy Sharplink Onchain Yield Fund, LP with US$125 million in capital. Together, these moves highlight Sharplink’s effort to turn a large ETH treasury into a more productive, institutionally managed onchain portfolio despite ongoing losses. We’ll...

International Bancshares earnings and dividend move draw investor focus International Bancshares (IBOC) is back in the spotlight after reporting second quarter 2026 results that showed higher net interest income but slightly softer net income, alongside a newly declared cash dividend of $0.73 per share. See our latest analysis for International Bancshares. International Bancshares shares have eased over the past month with a 30 day share price return of 2.96% lower. However, the year to date...

Match Group (MTCH) has been active this week, pairing a new US$257.75 million shelf registration for 6,250,000 ESOP related common shares with a fresh quarterly dividend, as well as recent earnings and buyback updates. See our latest analysis for Match Group. Match Group’s recent shelf registration, dividend announcement, earnings update and buyback completion have played out against a share price of US$37.95, with a 19.57% year to date share price return but a much weaker 5 year total...

In early August 2026, TransMedics Group reported second-quarter revenue of US$189.95 million and net income of US$14.68 million, with lower earnings per share than the same period a year earlier. Despite profit compression, the company raised the low end of its full-year 2026 revenue guidance to a range of US$737 million to US$757 million, signaling confidence in its top-line trajectory. Next, we’ll examine how the raised full-year revenue guidance reshapes TransMedics’ existing investment...

In August 2026, OPENLANE, Inc. completed a follow-on equity offering of 8,000,000 common shares at US$34.36 each, raising about US$274.88 million, following a period of higher 2026 net income guidance and stronger second-quarter earnings. This capital raise, coming soon after the company finished a US$98.74 million share repurchase program, highlights a rapid shift in capital allocation priorities and potential plans for funding future growth or balance sheet flexibility. We’ll now examine...

Sotera Health reported its second-quarter 2026 results, with revenue rising to US$321.38 million from US$294.34 million and net income increasing to US$53.64 million from US$7.96 million a year earlier, while earnings also improved sharply for the first half of the year. Beyond the headline growth, the company’s broad-based strength across Sterigenics, Nordion, and Nelson Labs, together with a raised full-year outlook, underlines how new capacity, pricing, and operational efficiencies are...

Schneider National (SNDR) moved into focus after its second quarter 2026 earnings report, which showed higher sales, increased net income and earnings per share, alongside a top Zacks Rank and progress on operational improvements. See our latest analysis for Schneider National. At a share price of US$36.10, Schneider National has seen solid momentum this year, with a year to date share price return of 33.85% and a 1 year total shareholder return of 49.76%. The 90 day share price return of...